20-year analysis of protocol-driven quality improvement in cardiac homograft banking.
- 1Institut Jantung Negara, 145 Jalan Tun Razak, 50400, Kuala Lumpur, Malaysia. [email protected].
- 2Institut Jantung Negara, 145 Jalan Tun Razak, 50400, Kuala Lumpur, Malaysia.
Abstract
Cardiac homografts are indispensable in complex cardiac surgery, particularly in the paediatric population. Optimising procurement and minimising discard rates are important for maintaining graft availability, especially in resource-limited settings. This study evaluated 20 years of cardiac homograft procurement at a tertiary cardiovascular centre, focusing on discard rates, causes of discard, microbiological profiles, and the impact of protocol refinements. A retrospective analysis was conducted using procurement records from the Cardiac Homograft Tissue Bank at the Institut Jantung Negara, Malaysia, between January 2004 and December 2024. The data collected included annual procurement volume, reasons for discarding, and microbiological culture results. In 2015, a revised procurement protocol was introduced, which incorporated instrument and operative field segregation, aseptic redraping, and enhanced donor screening. A total of 190 hearts were procured (mean 9.05 ± 4.18 hearts/year), with an overall discard rate of 13.7% (of 26/190). Prior to 2015, the discard rate was 17.2% (20/116), with environmental contamination accounting for the majority of the discards (75%; n=15). Fifteen microbial isolates were identified in the pre-revision period: Candida (n=6), Klebsiella (n=4), Acinetobacter (n=2), Streptococcus spp. (n=1), Streptococcus viridans (n=1), and Pseudomonas spp. (n=1). Following the 2015 protocol revision, the overall discard rate decreased to 8.1% (6/74), representing a 53% reduction, although this difference was not statistically significant (p=0.074). Environmental contamination-related discards decreased significantly from 12.9% (15/116) to 1.4% (1/74) (89% reduction; p=0.005), with only one Candida isolate identified post-revision. Protocol refinement has therefore produced a statistically significant reduction in contamination-related discards and a shift in the microbiological spectrum.
Related
- Reducing surgical site infections among paediatric patients undergoing cardiac surgery: a multi-disciplinary quality improvement initiative
- ITACARE-P cardiorehab registry: real-world data on quality and outcomes in heart failure and ischaemic heart disease - a prospective observational study protocol of the Italian early post-acute cardiac rehabilitation network.
- Implementing AI-assisted, patient-friendly imaging report summaries to enhance oncology care delivery: protocol for a randomized mixed-methods quality improvement study
- Serial 4-Dimensional Flow Cardiac Magnetic Resonance Imaging Visualizes Incremental Hemodynamic Improvement Following Alcohol Septal Ablation and Subsequent Mavacamten Therapy
- Anticholinergic Burden Scoring in Orthogeriatric Patients: A Two-Cycle Quality Improvement Audit
BibTeX
@article{baruji202620year,
title = {{20-year analysis of protocol-driven quality improvement in cardiac homograft banking.}},
author = {Muhammad Ashraff Baruji and Sharifah Noraida Syed Nong and Khairul Anuar Abdul Aziz and Mohd Nazeri Nordin and Mohamed Ezani Md Taib and Intan Fariza Gaaffar and Aini Syakirin Kepli and Ahmad Sallehuddin},
journal = {Cell and tissue banking},
year = {2026},
month = oct,
doi = {10.1007/s10561-026-10258-8},
url = {https://europepmc.org/article/MED/42900291},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - 20-year analysis of protocol-driven quality improvement in cardiac homograft banking.
AU - Muhammad Ashraff Baruji
AU - Sharifah Noraida Syed Nong
AU - Khairul Anuar Abdul Aziz
AU - Mohd Nazeri Nordin
AU - Mohamed Ezani Md Taib
AU - Intan Fariza Gaaffar
AU - Aini Syakirin Kepli
AU - Ahmad Sallehuddin
PY - 2026
DA - 2026/10/20
JO - Cell and tissue banking
DO - 10.1007/s10561-026-10258-8
UR - https://europepmc.org/article/MED/42900291
AB - Cardiac homografts are indispensable in complex cardiac surgery, particularly in the paediatric population. Optimising procurement and minimising discard rates are important for maintaining graft availability, especially in resource-limited settings. This study evaluated 20 years of cardiac homograft procurement at a tertiary cardiovascular centre, focusing on discard rates, causes of discard, microbiological profiles, and the impact of protocol refinements. A retrospective analysis was conducted using procurement records from the Cardiac Homograft Tissue Bank at the Institut Jantung Negara, Malaysia, between January 2004 and December 2024. The data collected included annual procurement volume, reasons for discarding, and microbiological culture results. In 2015, a revised procurement protocol was introduced, which incorporated instrument and operative field segregation, aseptic redraping, and enhanced donor screening. A total of 190 hearts were procured (mean 9.05 ± 4.18 hearts/year), with an overall discard rate of 13.7% (of 26/190). Prior to 2015, the discard rate was 17.2% (20/116), with environmental contamination accounting for the majority of the discards (75%; n=15). Fifteen microbial isolates were identified in the pre-revision period: Candida (n=6), Klebsiella (n=4), Acinetobacter (n=2), Streptococcus spp. (n=1), Streptococcus viridans (n=1), and Pseudomonas spp. (n=1). Following the 2015 protocol revision, the overall discard rate decreased to 8.1% (6/74), representing a 53% reduction, although this difference was not statistically significant (p=0.074). Environmental contamination-related discards decreased significantly from 12.9% (15/116) to 1.4% (1/74) (89% reduction; p=0.005), with only one Candida isolate identified post-revision. Protocol refinement has therefore produced a statistically significant reduction in contamination-related discards and a shift in the microbiological spectrum.
SN - 1389-9333
SN - 1573-6814
ER -